SCHEPIS, Filippo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.821
EU - Europa 3.404
AS - Asia 1.542
SA - Sud America 58
AF - Africa 34
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 7
Totale 13.875
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.794
GB - Regno Unito 1.148
IT - Italia 829
CN - Cina 510
SG - Singapore 488
SE - Svezia 455
DE - Germania 310
HK - Hong Kong 241
UA - Ucraina 152
RU - Federazione Russa 123
FI - Finlandia 98
TR - Turchia 95
BG - Bulgaria 86
ID - Indonesia 85
FR - Francia 52
BR - Brasile 35
VN - Vietnam 32
LT - Lituania 24
CA - Canada 19
IN - India 19
NL - Olanda 19
BE - Belgio 18
EG - Egitto 16
RO - Romania 15
MY - Malesia 14
ES - Italia 13
AU - Australia 9
IE - Irlanda 9
KR - Corea 9
CZ - Repubblica Ceca 8
CH - Svizzera 7
CO - Colombia 7
CL - Cile 6
EU - Europa 6
PE - Perù 6
SC - Seychelles 6
ZA - Sudafrica 6
HU - Ungheria 5
JP - Giappone 5
TH - Thailandia 5
AT - Austria 4
BZ - Belize 4
PK - Pakistan 4
PL - Polonia 4
SI - Slovenia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BD - Bangladesh 3
GR - Grecia 3
HR - Croazia 3
IL - Israele 3
NP - Nepal 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
AZ - Azerbaigian 2
BO - Bolivia 2
EE - Estonia 2
GE - Georgia 2
IR - Iran 2
LV - Lettonia 2
MA - Marocco 2
MX - Messico 2
QA - Qatar 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
DZ - Algeria 1
EC - Ecuador 1
IM - Isola di Man 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
NO - Norvegia 1
PA - Panama 1
PT - Portogallo 1
SA - Arabia Saudita 1
TM - Turkmenistan 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 13.875
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.329
Fairfield 1.227
Southend 972
Woodbridge 726
Ashburn 651
Chandler 600
Houston 562
Seattle 483
Cambridge 415
Wilmington 405
Singapore 385
Ann Arbor 327
Nyköping 322
Modena 313
Jacksonville 309
Dearborn 255
Hong Kong 238
San Diego 118
Beijing 115
Princeton 96
Sofia 86
Jakarta 84
New York 76
Izmir 71
Helsinki 62
Eugene 56
Redwood City 50
London 49
Moscow 48
Bologna 43
Grafing 39
Shanghai 37
Milan 36
Des Moines 32
Nanjing 28
Bremen 26
Boardman 22
Falls Church 22
Guangzhou 21
Brussels 18
Hefei 17
Wuhan 16
Hanoi 15
Chicago 13
Munich 13
Jinan 12
Norwalk 12
Rome 12
Dong Ket 11
Los Angeles 11
Ottawa 10
Bari 9
Dublin 9
Kilburn 9
Paris 9
Carpi 8
Chiswick 8
Frankfurt am Main 8
Kunming 8
Saint Petersburg 8
San Jose 8
Brno 7
Fremont 7
Napoli 7
Padova 7
Parma 7
Prescot 7
Reggio Emilia 7
Rho 7
Amsterdam 6
Augusta 6
Cairo 6
Castelnuovo Rangone 6
Dallas 6
Ferrara 6
Hounslow 6
Mahé 6
Mumbai 6
São Paulo 6
Toronto 6
Wenzhou 6
Andover 5
Florence 5
Johannesburg 5
Kuala Lumpur 5
Lappeenranta 5
Morengo 5
Naples 5
San Mateo 5
Seongnam 5
Sydney 5
Tanta 5
Timisoara 5
Verona 5
Acton 4
Baotou 4
Belize City 4
Buffalo 4
Council Bluffs 4
Fuzhou 4
Totale 11.197
Salva come PNG Salva come JPEG
Nome #
Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease 596
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 323
Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals 320
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study 304
PROGRESSIVE ALTERATIONS IN SYSTEMIC AND CARDIOPULMONARY HEMODYNAMICS OCCUR IN PATIENTS WITH CIRRHOSIS AND PREDICT DEATH IN DECOMPENSATED CIRRHOSIS 261
ANTICOAGULANT THERAPY IS SAFE AND EFFECTIVE IN PREVENTING PORTAL VEIN THROMBOSIS (PVT) IN ADVANCED CIRRHOTIC PATIENTS: A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 251
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 242
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis 238
Cardiopulmonary hemodynamics and c-reactive protein as prognostic indicators in compensated and decompensated cirrhosis 237
A new device for ultrasound-guided peripheral venous access 227
Consensus conference on TIPS management: Techniques, indications, contraindications 212
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 201
Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. 195
Liver steatosis and non-alcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV 195
Obese zebrafish: A small fish for a major human health condition 194
Cloning and molecular characterization of a novel gene strongly induced by the adenovirus E1A gene in rat thyroid cells. 193
Low molecular weight heparin does not increase bleeding and mortality post endoscopic variceal band ligation in cirrhotic patients 189
De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients 188
JLB: a flexible and effective device in critical patients. Review of clinical cases 188
ENOXAPARIN PREVENTS PORTAL VEIN THROMBOSIS (PVT) AND DECOMPENSATION IN ADVANCED CIRRHOTIC PATIENTS: FINAL REPORT OF A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 187
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 187
The cl2/dro1/ccdc80 null mice develop thyroid and ovarian neoplasias 185
Complete resolution of non-necrotizing lung granuloma and pyoderma gangrenosum after restorative proctocolectomy in a woman with severe ulcerative colitis and cytomegalovirus infection 185
30 Days of continuous olanzapine infusion determines energy imbalance, glucose intolerance, insulin resistance, and dyslipidemia in mice. 184
Ccdc80-l1 Is involved in axon pathfinding of zebrafish motoneurons. 184
Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis 183
Prevention and Management of Bleeding Risk Related to Invasive Procedures in Cirrhosis 183
A RANDOMIZED TRIAL OF THE SAFETY AND HEPATIC HEMODYNAMIC EFFECTS OF INTRAVENOUS CONIVAPTAN IN EUVOLEMIC OR HYPERVOLEMIC CIRRHOTIC PATIENTS 177
PROCALCITONIN IS THE BEST DIAGNOSTIC AND PROGNOSTIC MARKER OF SEPSIS IN DECOMPENSATED CIRRHOTIC PATIENTS 176
Thrombophilic genetic risk factors for liver fibrosis: To screen or not to screen? 175
Reply to: “Relationship of hyperdynamic circulation and cardiodynamic states in cirrhosis” 170
Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data. 170
Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? 166
Study of the Serum Metabolomic Profile in Nonalcoholic Fatty Liver Disease: Research and Clinical Perspectives 165
Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: A case-control study 164
LOW MOLECULAR WEIGHT HEPARIN TREATMENT DOES NOT INCREASE THE RISK OF BLEEDING AFTER PROPHYLACTIC ENDOSCOPIC VARICEAL BAND LIGATION IN PATIENTS WITH CIRRHOSIS 163
Paradoxical embolization in TIPS: take a closer look to the heart 162
Chemoprevention of hepatocellular carcinoma 161
Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors. 161
The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity. 158
Effects of simvastatin treatment on sICAM-1 and sE-selectin levels in hypercholesterolemic subjects. 155
Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data. 154
Transjugular intrahepatic portosystemic shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: a real-life, case-control study 147
Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis. 145
Protection of human endothelial cells from oxidative stress: Role of Ras-ERK1/2 signaling 144
Guide-wire replacement of a mini-midline catheter with a central venous catheter: A retrospective study on 63 cases 144
Angiopoietin-2/Tie2 Inhibition by Regorafenib Associates With Striking Response in a Patient With Aggressive Hepatocellular Carcinoma 142
Transarterial chemoembolization for unresectable hepatocellular carcinoma: Meta-analysis of randomized controlled trials 141
The Coiled-Coil Domain Containing 80 (ccdc80) gene regulates gadd45β2 expression in the developing somites of zebrafish as a new player of the hedgehog pathway 140
MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1 137
Preoperative chemoradiotherapy for oesophageal cancer: A systematic review and meta-analysis 136
When and how to treat acute hepatitis C? 133
Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up study 132
Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19 131
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: a long-term follow-up study 122
An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo. 116
Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis 114
Pathophysiology of portal hypertension and variceal bleeding 112
Meta-analysis of Transarterial Embolization in Patients with Unresectable Hepatocellular Carcinoma: Dr Camma and colleagues respond 111
Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives 109
Natural history of chronic HBV in northern Italy: Morbidity and morality after 30 years 106
Tumor suppressor role of the CL2/DRO1/CCDC80 gene in thyroid carcinogenesis 104
Transient elastography and ultrasonography: Optimal evaluation of liver fibrosis and cirrhosis in patients with chronic hepatitis B concurrent with nonalcoholic fatty liver disease 97
Prevalence, Predictors, and Severity of Lean Nonalcoholic Fatty Liver Disease in Patients Living With Human Immunodeficiency Virus 96
Erratum: Unusual association between Budd-Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: A case report and review of the literature (Clinical Rheumatology (2013) 32 (905-907) DOI: 10.1007/s10067-013-2229-z) 93
Akt1/Akt2 inhibition and development of hepatocellular carcinoma 93
Baveno VII – Renewing consensus in portal hypertension 92
Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons with HIV infection and Compensated Advanced Chronic Liver Disease 89
The OMICs window into nonalcoholic fatty liver disease (NAFLD) 89
Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes 88
Monitoring Treatment of Cirrhosis and Portal Hypertension 85
The role of transjugular intrahepatic portosystemic shunt in patients with cirrhosis and ascites: Recent evolution and open questions 83
Cardiodynamic state is associated with systemic inflammation and fatal acute-on-chronic liver failure 83
Reply to: “It takes two “eyes” to see in depth” 81
Portal Hypertension and Ascites: Patient-and Population-centered Clinical Practice Guidelines by the Italian Association for the Study of the Liver (AISF) 77
Relevance of spontaneous portosystemic shunts detected with CT in patients with cirrhosis 77
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma 76
Quality of life in liver transplant recipients during the Corona virus disease 19 pandemic: A multicentre study 74
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 68
Baveno IV Consensus Statements: Predictive Models in Portal Hypertension 68
Effects of sildenafil on right ventricle remodelling in Portopulmonary hypertension 64
Retraction: The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD) (Metabolites 2019, 9(2), 25) 63
Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation 63
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model 61
Proximal Splenic Artery Embolization to Treat Refractory Ascites in a Patient With Cirrhosis 60
Reply to: “The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites” 59
Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease 56
Portosystemic shunt is an effective treatment for complications of portal hypertension in hepatic myeloid metaplasia and improves nutritional status 55
Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis 51
Upregulation of the oestrogen target gene SIX1 is associated with higher growth speed and decreased survival in HCV-positive women with hepatocellular carcinoma 48
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study 48
The use of intrahepatic portosystemic shunt in HIV positive patients: A retrospective multicentric study 46
GALAD outperforms aMAP and ALBI for predicting HCC in patients with compensated advanced chronic liver disease: A 12-year prospective study 43
Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids 42
Endoscopic radiofrequency ablation for the treatment of severe gastric antral vascular ectasia in patients with cirrhosis 40
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease 34
Physical activity in liver transplant recipients: a large multicenter study 34
Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS 33
Corrigendum to ‘Baveno VII – Renewing consensus in portal hypertension’ [J Hepatol (2022) 959-974, (S0168827821022996), (10.1016/j.jhep.2021.12.022)] 32
Endovascular Assessment of Liver Hemodynamics in Patients with Cirrhosis Complicated by Portal Hypertension 32
Totale 13.748
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.847
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.847
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.180 0 0 0 0 0 0 383 235 236 108 122 96
2020/20212.531 132 156 204 313 339 221 157 288 109 325 183 104
2021/20221.883 132 156 157 66 76 111 132 158 213 148 321 213
2022/20231.751 216 209 140 164 156 261 21 179 183 29 129 64
2023/20241.173 51 63 79 120 185 91 154 114 66 21 91 138
2024/20252.382 139 66 67 343 1.000 755 12 0 0 0 0 0
Totale 14.109